Angiotensin receptor blockers (ARBs) do not increase risk, the FDA reported, after investigating the medications following a study last year suggesting there might be a small risk. The FDA's (Food and Drug Administration's) one-year safety review reported that it found no evidence of an ...
angiotensin-receptor blocker noun : any of a class of drugs (as losartan and valsartan) that block the effects of angiotensin II by inhibiting access to a subset of its receptors and that are used especially in the treatment of hypertension —abbreviation ARB See the full definition ...
angiotensin receptor blockers TW Kurtz and U Klein 828 enzyme inhibitors or angiotensin receptor blockers with diuretics have increased significantly in market share, and the recent FDA approval of Exforge HCT (a combination of the ARB valsartan, the calcium channel blocker amlodipine and the ...
1. 血管紧张素受体阻断剂 现阶段临床试验显示作用於治疗心脏 衰竭,血管紧张素受体阻断剂(angiotensin-receptor blockers)并无优於血 管紧张素转化酶 …www.docin.com|基于1 个网页 例句 释义: 全部,血管紧张素受体阻断剂 更多例句筛选 1. it ' s a very , very important study addressing the issue of the...
Angiotensin receptor type 1 blockers (ARBs), used to treat hypertension and heart failure, are commonly administered in combination therapy. However, their interaction potential is not well studied and their effect on ABC-transporters remains elusive. The study therefore aimed to elucidate the effect...
Angiotensin receptor blockers improve functional outcome and reduce all-cause mortality in patients discharged after acute ischemic strokeAngiotensin receptor blockers improve functional outcome and reduce all-cause mortality in patients discharged after acute ischemic strokeWe aimed todoi...
Subgroup analysis by the type of drugs taken by controls revealed significant reductions in SBP Angiotensin receptor blockers and arterial stiffness F Peng et al for comparisons of ARBs with placebo (WMD = − 3.81 mm Hg; 95% CI: − 6.70 to − 0.91; P = 0.010; I2 = 77.2%) and ...
Semmelweis University, First Medical Clinic, Korányi S. u. 2/a, 1083 Budapest, HungaryWiley‐VCH Verlag GmbH & Co. KGaAFarsang C, Fischer J. Optimizing antihypertensive therapy by angiotensin receptor blockers. In: Fischer J, Robin Ganellin C, eds. Analogue-based drug discovery. Weinheim, ...
Revelation on the potency of α(1) -blockers - parallel blockade of angiotensin II receptor: a new finding. 来自 NCBI 喜欢 0 阅读量: 23 作者:Yadav, M. R,Gandhi, H. P,Naik, P. P,Giridhar, R 摘要: The problem of hypertension has gained enormous proportions in the past decade. ...
Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology 2009; 9: 786-92.Sjoberg BT, Garcia RLA, Lindblad M. Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study...